Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 37kWORD 18k
6 March 2020
Answer given by Ms Kyriakides
on behalf of the European Commission
Question reference: E-000257/2020

1. The Commission has discussed the implementation of the Court ruling on Case C‐528/16(1) on mutagenesis with the Member States experts in several Standing Committee meetings, with the goal to ensure that the legislation on genetically modified organisms (GMOs) is implemented as interpreted by the Court.

Furthermore, based on Article 241 of the Treaty on the Functioning of the European Union(2), the Council has requested the Commission(3) to submit a study, by 30 April 2021, regarding the status of novel genomic techniques (NGTs) under Union law in light of the Court of Justice’s judgment in Case C-528/16.

In the study, the Commission intends to provide a state-of-play on the implementation and enforcement of the GMO legislation, as regards NGTs, based inter alia on contributions from targeted consultations of Member States and stakeholders.

2. The abovementioned study will also take into account past and ongoing work of the European Union Reference Laboratory and the European Network of GMO Laboratories, on the detection of products obtained by certain NGTs.

3. Member States are responsible for the enforcement of the GMO legislation. Economic operators both within and outside the EU territory have the burden of proof that products placed on the EU market, whether imported or produced in the EU, fulfil the requirements of the legislation.

This includes verification that unauthorised GMOs are not placed on the market and that traceability and labelling rules for authorised GMOs (as set by the EU legislation) are fulfilled.

(3)OJ L 293, 14.11.2019, p. 103‐104.
Last updated: 6 March 2020Legal notice - Privacy policy